News from PROT

crwefinancelogo2 signup3m PROTEONOMIX, INC

crwefinancelogo2 signup3m PROTEONOMIX, INC. (Pinksheets:PROT), a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives, applauds the actions taken by the Costa Rican Ministry of Health to crack down on unauthorized stem cell clinics. The chief of the ministry's research council, Dr. Ileana Herrera, stated, If (stem cell treatment's) efficacy and safety has not been proven, we don't believe it should be used. Mr. Michael Cohen, Chairman and CEO of Proteonomix, stated, We have no doubt that stem cell therapies will be a major factor in combating a variety of medical conditions but it is essential that it be undertaken only after the clinical results determine that such a course of action is efficacious. Too much hype about cures for all types of diseases is diminishing the potential value of stem cells and could unduly delay future progress in stem cell treatments and research. Medical tourism is not a dirty word, if established in an ethical and professional manner. PROT is a biotechnology company focused on developing therapeutics based upon the use of human cells and their derivatives. Proteoderm, Inc. a wholly owned subsidiary of Proteonomix that has recently opened its retail web site, Proteoderm.com, and begun accepting pre-orders for its anti-aging skin care products. For more information please http://www.proteonomix.com http://crwefinance.com/img/crwefinance_new_buscard2.jpg Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings, Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (read more ) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) has received twenty thousand dollars in cash and twenty thousand dollars in free trading shares from a third party (Swiss Financial Report) for (30) days of advertisement services for Proteonomix, Inc. (PROT.OB)

News from PROT

By: Justin

POST COMMENT

Sun Powered Battery Charger Short Guide In Choosing Laser Pointer When Glands Produce Too Much Oil Words to Ponder Open Letter to National Urban League President Mark Morial Aloe Vera Gel – The Natural Wonder Confie nestes 5 e será potente Kingsbridge Cathedral - Where Stories Find Their Meaning Butcher Paper for Your Multifarious Needs Boys tracksuits make a lot of sense Essential Pim - Your Free Pda Proactive vs Reactive Remote IT Support Why Use Customized Lanyards?